| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |